The cancer you've never heard of
by Brandpoint (ARA) Sponsored Content
Jan 17, 2014 | 20261 views | 0 0 comments | 66 66 recommendations | email to a friend | print

(BPT) - When Sue Hollingsworth was diagnosed with advanced medullary thyroid cancer (aMTC), she had never even heard of the disease, let alone met another patient like her. Feeling isolated and unable to find information to best prepare herself for what the future held, she began writing letters for her daughter to read after her passing.

'My daughter was 9, and I didn't know if I would be around when she turned 16, when she went to her first prom. These were things that bothered me,' says Hollingsworth.

Facing a diagnosis of thyroid cancer can be terrifying for anyone. And that fear can be compounded with a rare form of thyroid cancer such as medullary thyroid cancer. Of the more than 60,000 cases of thyroid cancer expected to be diagnosed in 2014, only about 4 percent will be MTC. Even more uncommon is MTC that is advanced, which means that it has spread beyond the thyroid gland.

While there is no cure for aMTC, treatments are available to help patients. Still, many patients living with aMTC can feel isolated and neglected by a lack of information geared toward their unique issues. They continue to face friends and family who don't understand why their disease is different than more common forms of thyroid cancer, and few programs are available for awareness and support.

'Many people don't understand that advanced MTC is a very different diagnosis than other types of thyroid cancer. A number of cancers are still considered rare diseases, and living - and caring for those living - with these rare diseases can be exceptionally difficult,' says Gary Bloom, executive director of ThyCa: Thyroid Cancer Survivors' Association, Inc.

ThyCa and other key organizations are working to raise awareness of aMTC and provide resources for those affected by the disease, reminding patients and caregivers that support is available.

For Hollingsworth, her journey is a difficult one but now filled with encouragement from her loved ones and personal strength for the road ahead. 'Since being diagnosed, I have become more active in my community. I spend a lot less time filling my time, and more time thinking about the value of the things I'm involved in,' she says.

Visit for videos about aMTC from AstraZeneca and to see Hollingsworth's story. To access information and support services for those living with aMTC, visit ThyCa at The site provides a free handbook, one of the first of its kind, that contains disease information, treatment options, advances in research and tips for finding a specialist with experience managing MTC.

Copyright 2013 The Times-Independent. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

report abuse...

Express yourself:

We're glad to give readers a forum to express their points of view on issues important to this community. That forum is the “Letters to the Editor.” Letters to the editor may be submitted directly to The Times-Independent through this link and will be published in the print edition of the newspaper. All letters must be the original work of the letter writer – form letters will not be accepted. All letters must include the actual first and last name of the letter writer, the writer’s address, city and state and telephone number. Anonymous letters will not be accepted.

Letters may not exceed 400 words in length, must be regarding issues of general interest to the community, and may not include personal attacks, offensive language, ethnic or racial slurs, or attacks on personal or religious beliefs. Letters should focus on a single issue. Letters that proselytize or focus on theological debates will not be published. During political campaigns, The Times-Independent will not publish letters supporting or opposing any local candidate. Thank you letters are generally not accepted for publication unless the letter has a public purpose. Thank you letters dealing with private matters that compliment or complain about a business or individual will not be published. Nor will letters listing the names of individuals and/or businesses that supported a cause or event. Thank you letters about good Samaritan acts will be considered at the discretion of the newspaper.